v3.26.1
Schedule of Financial Data for the Company’s Reportable Segment (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Segment Reporting [Line Items]        
Research and development expenses $ 302 $ 1,860 $ 1,080 $ 2,776
Total operating costs and expenses 3,002 4,952 6,658 8,568
Operating loss (3,002) (4,952) (6,658) (8,568)
Other income (expenses):        
Other expense (1,536) (1,023) (1,826) (1,992)
Loss on investment (86) (154)
Interest income 4 12
Interest expense, net (17) (57) (66) (233)
Total other expense, net (1,639) (1,076) (2,046) (2,213)
Net loss (4,641) (6,028) (8,704) (10,781)
Clinical Asset Development [Member]        
Segment Reporting [Line Items]        
Research and development expenses 185 222 447 411
Related Parties [Member]        
Segment Reporting [Line Items]        
Research and development expenses 117 1,638 633 2,365
Legal and Professional Fees [Member]        
Segment Reporting [Line Items]        
General and administrative expenses 300 872 1,013 1,632
Accounting and Audit Fees [Member]        
Segment Reporting [Line Items]        
General and administrative expenses 639 378 1,348 922
Salaries Payroll and Stock Based Compensation [Member]        
Segment Reporting [Line Items]        
General and administrative expenses 470 751 1,013 1,444
Other [Member]        
Segment Reporting [Line Items]        
General and administrative expenses $ 1,291 $ 1,091 $ 2,204 $ 1,794